Atlas Trials

A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Clinical trial NCT03241550 · COMPLETED

Trial details

NCT number
NCT03241550
Sponsor
Astellas Pharma Global Development, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hematological Malignancy
Start date
2017-10-02
Primary completion
2019-07-05
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.